Table 1.

Characteristic of patients included in the study.

NrGenderAge at biopsyrs815 (IFNL4)HCV genotypeLog10 (viral load)MetavirFACSImmunohistochemistry
1f64ΔG/ΔG1b5.44A2/F1XX
2m58ΔG/ΔG3a5.47A3/F3XX
3m24ΔG/ΔG14.81A1/F0XX
4m49ΔG/ΔG46.50A1/F1X
5m61ΔG/ΔG1bn.aA2/F2X
6m51ΔG/ΔG1b5.75A2/F4X
7m40ΔG/ΔG3a5.66A1/F1X
8f53ΔG/ΔG4a/c/d5.90A3/F3X
9m48ΔG/ΔG4a/c/d6.03A2/F2X
10m30ΔG/ΔG1a5.03A1/F1X
11m24ΔG/ΔG1a5.26A1/F0X
12m52TT/ΔG3a6.69A2/F2XX
13m56TT/ΔG3a5.75A3/F4XX
14m50TT/ΔG1a6.92A3/F2XX
15f37TT/ΔG1an.aA1/F2XX
16m46TT/ΔG4a/c/d5.06A3/F4XX
17m45TT/ΔG1b5.25A1/F1XX
18M15TT/ΔG1a5.44A1/F1X
19f47TT/ΔG1a6.78A2/F4X
20m45TT/ΔG1a6.21A2/F2X
21m42TT/TT3a6.98A2/F1XX
22f52TT/TT4n.aA2/F2XX
23m77TT/TT1b5.92A2/F3XX
24m61TT/TT1an.aA2/F1XX
25m43TT/TT15.97A1/F1X
26f45TT/TT3a5.06A1/F1X
27f45TT/TT1b6.38A2/F1X
28m53TT/TTn.a6.47A2/F2X
29f52TT/TT1a6.09A2/F1X
30m36TT/TT3a5.90A1/F1X
31m43TT/TT1a3.60A1/F1X
32m39TT/TT3a6.41A1/F1X
33f41TT/TT1b6.44A2/F3X
34m50TT/TT3a6.52A2/F1X
35m53TT/TT3a6.52A3/F4X
36m56TT/TT1a6.80A3/F3X
37m45TT/TT3a5.87A2/F4X
38f37TT/TT1a6.19A2/F3X
39m53TT/TT46.12A1/F1X